Diginex launches supply chain due diligence solution
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- S&P Global explores potential separation of Capital IQ business
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- Equities end higher as Anthropic's IPO filing buoys AI stocks
Diginex Expands Supply Chain End-to-End Product Suite Amid Accelerating Regulatory Pressure
June 4, 2026 8:00 AM EDTIn a human rights and supply chain due diligence market valued at approximately $3.8 billion in 2025, non-compliance carries material, financial and reputational consequences.
Diginexs Risk-to-Remedy is an end-to-end solution supporting supply chain transparency and risk surfacing to enable faster, evidence-based action and more defensible reporting.
Upcoming enhancements to Diginexs supply chain offering will enable businesses to make smarter decisions, take effective action and measure outcomes.
LONDON, June 04, 2026 (GLOBE NEWSWIRE) -- Diginex Limited (Nasdaq: DGNX), a provider of ESG,... More



